July 31, 2014: Gilead Sciences was held by 13 13-F filings. When hedge fund managers appear to be thinking alike, we find it is a good idea to take a closer look.
July 31, 2014: Alan Auerbach hit the jackpot when stock of Puma Biotechnology, the drug company he founded, skyrocketed 295% on July 23 following good news from a Phase III clinical trial of an experimental breast cancer drug that Puma licensed from Pfizer.
July 31, 2014: Wall Street bulls love Valeant Pharmaceuticals' lean business model, but there are side effects they aren't aware of that might give them pause.
July 31, 2014: Aside from making lots of money for book publishers and film studio/theme-park conglomerates, what has Harry Potter done for us lately...